WNDW SolarWindow Technologies, Inc.
Industrial Organic Chemicals · OTC · SEC CIK 1071840 · Fiscal year ends 08/31
Financial factors as of 2026-05-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY1.4%
TTM EPS YoY-0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-61.9%
ROA-56.7%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets6.3%
Debt / equity0.00x
Current ratio15.80x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-05-31 | 2026Q22026-02-28 | 2025Q12025-11-30 | 2025Q4*2025-08-31 | 2025Q32025-05-31 | 2025Q22025-02-28 | 2025Q12024-11-30 | 2024Q4*2024-08-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | $0 |
| R&D expense | $174,013 | $170,635 | $148,851 | $143,727 | $167,643 | $173,335 | $137,179 | $182,764 |
| SG&A expense | $552,995 | $453,311 | $464,338 | $394,358 | $385,865 | $495,692 | $457,952 | $497,658 |
| Operating income | -$727,008 | -$623,946 | -$613,189 | -$538,085 | -$553,508 | -$669,027 | -$595,131 | -$680,420 |
| Net income | -$696,406 | -$589,420 | -$570,758 | -$505,409 | -$545,719 | -$654,087 | -$552,063 | -$644,699 |
| EBITDA | -$722,121 | -$619,058 | -$609,290 | -$535,125 | -$551,558 | -$667,526 | -$593,486 | -$678,514 |
| EPS (basic) | -0.01 | -0.01 | -0.01 | — | -0.01 | -0.01 | -0.01 | — |
| EPS (diluted) | -0.01 | -0.01 | -0.01 | — | -0.01 | -0.01 | -0.01 | — |
| Weighted avg. shares (diluted) | 65.78M | 65.78M | 65.78M | — | 53.20M | 53.20M | 53.20M | — |
| Banking | ||||||||
| Net interest income | $30,602 | $34,526 | $42,431 | $48,116 | $13,215 | $38,983 | $44,039 | $31,875 |
| Balance sheet | ||||||||
| Cash & equivalents | $4.79M | $5.39M | $5.90M | $6.56M | $3.24M | $3.80M | $721,879 | $1.25M |
| Short-term investments | — | — | — | — | — | — | $3.00M | $3.00M |
| Current assets | $4.84M | $5.51M | $6.06M | $6.60M | $3.41M | $3.93M | $4.53M | $4.99M |
| PP&E, net | $60,724 | $64,167 | $69,054 | $43,089 | $16,453 | $10,312 | $11,813 | $13,458 |
| Total assets | $4.90M | $5.57M | $6.12M | $6.65M | $3.43M | $3.94M | $4.54M | $5.00M |
| Current liabilities | $306,365 | $278,389 | $244,534 | $194,175 | $390,956 | $357,576 | $360,386 | $321,512 |
| Total liabilities | $306,365 | $278,389 | $244,534 | $194,175 | $390,956 | $357,576 | $360,386 | $321,512 |
| Shareholders' equity | $4.59M | $5.29M | $5.88M | $6.45M | $3.03M | $3.58M | $4.18M | $4.68M |
| Shares outstanding | 65.78M | 65.78M | 65.78M | 65.78M | 53.20M | 53.20M | 53.20M | 53.20M |
| Cash flow statement | ||||||||
| Operating cash flow | -$601,023 | -$506,179 | -$627,778 | -$498,846 | -$551,759 | $75,641 | -$527,567 | -$591,652 |
| Capital expenditure | — | — | — | — | — | — | — | $1 |
| Free cash flow | — | — | — | — | — | — | — | -$591,653 |
| Investing cash flow | -$1,486 | $0 | -$29,864 | -$29,596 | -$8,091 | — | — | $1.00M |
| Depreciation & amortization | $4,887 | $4,888 | $3,899 | $2,960 | $1,950 | $1,501 | $1,645 | $1,906 |
| Stock-based compensation | — | — | — | $0 | $0 | $51,562 | $51,563 | $51,562 |
Free plan shows the latest 8 periods; Pro shows all 64 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.